Eligi
Med
Ensayos clínicos
Suscripción
Sobre EligiMed
Ensayos Clínicos de Neurología | EligiMed
Ensayos clínicos
8.676 ensayos encontrados
Completado
ClinicalTrials.gov
A Multicenter, Prospective, Non-interventional Study to Assess Adherence to Treatment for patIeNts With RMS Who Are Prescribed Subcutaneous (sc) Interferon Beta-1a (MAIN-MS)
OBSERVATIONAL
Inicio: 30 de jun de 2016
ID: NCT02921035
Desconocido
ClinicalTrials.gov
A Randomized 3-Month, Parallel-Group, Controlled Trial of CALMA M-Health App as an Adjunct to Therapy for the Reduction of Suicidal and Non-Suicidal Self-Injurious Behaviors in Adolescents
INTERVENTIONAL
Inicio: 24 de feb de 2022
ID: NCT05453370
Completado
Fase 3
ClinicalTrials.gov
Sub-study to the A2M Study to Evaluate the Pharmacokinetics, Tolerability and Efficacy of Cabotegravir and Rilpivirine Long-Acting Injections Following Intramuscular Administration in the Vastus Lateralis Muscle (Thigh) in HIV-infected Adult Participants Who Have Received at Least Three Years of Gluteal Injections in the A2M Study
INTERVENTIONAL
Inicio: 28 de oct de 2021
ID: NCT05896761
Completado
Fase 3
ClinicalTrials.gov
A Randomized, Placebo Controlled, Multicenter Clinical Study Investigating Efficacy of Rituximab in the Inhibition of Joint Structural Damage Assessed by Magnetic Resonance Imaging in Patients With Rheumatoid Arthritis and Inadequate Response to Methotrexate
INTERVENTIONAL
Inicio: 1 de nov de 2007
ID: NCT00578305
Completado
Fase 3
ClinicalTrials.gov
An Open Label, Multicenter, Safety and Pharmacokinetic Study of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures
INTERVENTIONAL
Inicio: 3 de ago de 2016
ID: NCT02535091
Reclutando
Fase 3
ClinicalTrials.gov
A Randomized, Open-label, Parallel-group, Non-inferiority Study Comparing Efficacy, Safety, and Tolerability of Remibrutinib After Switching From Ocrelizumab in Participants Living With Relapsing Multiple Sclerosis, Followed by Open-label Treatment With Remibrutinib
INTERVENTIONAL
Inicio: 23 de jul de 2025
ID: NCT06846281
Completado
Fase 4
ClinicalTrials.gov
An Open-Label Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Etravirine (ETR) in Combination With Other Antiretrovirals (ARVs) in Antiretroviral Treatment-Experienced HIV-1 Infected Subjects
INTERVENTIONAL
Inicio: 1 de sept de 2011
ID: NCT01422330
Activo, no recluta
Fase 2
ClinicalTrials.gov
A Phase 2b, Multi-center, Randomized, Quadruple-blind, Placebo-controlled Study of Batoclimab Treatment in Adult Participants With Active Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
INTERVENTIONAL
Inicio: 15 de dic de 2022
ID: NCT05581199
Desconocido
ClinicalTrials.gov
Randomized, Triple-blind, Placebo Controlled Study to Evaluate the Efficacy of Individualized Homeopathic Remedies With High Grade of Pathological Similarity vs Conventional Standardized Pharmacological Treatment in Patients With Migraine.
INTERVENTIONAL
Inicio: 1 de mar de 2019
ID: NCT05468801
Completado
Fase 2
ClinicalTrials.gov
A 10-week Randomized, Double-blind, Placebo-controlled, Prospective, International, Multicentre, Phase IIa Study of S42909 on Leg Ulcer Healing.
INTERVENTIONAL
Inicio: 12 de sept de 2017
ID: NCT03077165
Completado
Fase 3
ClinicalTrials.gov
Multicenter, Open-label Study to Evaluate the Safety and Efficacy (by Blinded Reading) of Contrast-Enhanced Magnetic Resonance Angiography (MRA) After a Single Intravenous Injection of 0.1 mmol/kg Gadobutrol in Subjects With Known or Suspected Vascular Disease of the Supra-aortic Vessels
INTERVENTIONAL
Inicio: 12 de may de 2011
ID: NCT01344447
Completado
Fase 2
ClinicalTrials.gov
A Phase II Open-label, Randomized, Three-arm, Multicenter Study of LAG525 Given in Combination With Spartalizumab (PDR001), or With Spartalizumab and Carboplatin, or With Carboplatin, as First or Second Line Therapy in Patients With Advanced Triple-negative Breast Cancer
INTERVENTIONAL
Inicio: 2 de jul de 2018
ID: NCT03499899
Reclutando
ClinicalTrials.gov
Effectiveness of Carotid Sinus Massage in Modified Trendelenburg Position for Acute Headache Episodes: A Pilot Study
INTERVENTIONAL
Inicio: 21 de dic de 2024
ID: NCT06745648
Retirado
ClinicalTrials.gov
Prevalence of Amyloidosis in Carpal Tunnel Surgery
OBSERVATIONAL
Inicio: 1 de jun de 2017
ID: NCT02152644
Completado
Fase 3
ClinicalTrials.gov
A Double-Blind, Randomized, Placebo-Controlled, 5-Arm Titration Study to Evaluate the Efficacy and Safety of TAK-491 When Compared With Valsartan and Olmesartan in Subjects With Essential Hypertension
INTERVENTIONAL
Inicio: 1 de abr de 2008
ID: NCT00696436
Completado
ClinicalTrials.gov
Personal Protective Equipmente Needs, Perceptions and Acute Stress Among Healthcare Workers Caring for COVID-19 Patients in South America
OBSERVATIONAL
Inicio: 1 de abr de 2020
ID: NCT04486404
Completado
Fase 3
ClinicalTrials.gov
A 24-week, Randomized, Double-blind, Multi-center, Parallel LCZ696 on NT-proBNP, Exercise Capacity, Symptoms and Safety Compared to Individualized Medical Management of Comorbidities in Patients With Heart Failure and Preserved Ejection Fraction
INTERVENTIONAL
Inicio: 22 de ago de 2017
ID: NCT03066804
Completado
Fase 2
ClinicalTrials.gov
Safety and Efficacy of 333369 in the Treatment of Partial Epilepsy
INTERVENTIONAL
Inicio: 1 de feb de 2005
ID: NCT00228969
Reclutando
ClinicalTrials.gov
Evaluation of Functional Recovery of Facial Paralysis in People With Different Kinesic Treatment Options.
INTERVENTIONAL
Inicio: 1 de jun de 2023
ID: NCT06532903
Reclutando
Fase 3
ClinicalTrials.gov
A Master Protocol to Investigate the Efficacy and Safety of Orforglipron Once Daily in Participants With Hypertension and Obesity or Overweight: Randomized, Double-Blind, Placebo-Controlled Trials (ATTAIN-HYPERTENSION)
INTERVENTIONAL
Inicio: 30 de abr de 2025
ID: NCT06948435
Anterior
1
...
11
12
13
...
434
Siguiente
Filtros